Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic disease
Tóm tắt
Từ khóa
Tài liệu tham khảo
Humphreys, 2012, Targeting pericyte differentiation as a strategy to modulate kidney fibrosis in diabetic nephropathy, Semin Nephrol, 32, 463, 10.1016/j.semnephrol.2012.07.009
Ke, 2012, Hepatitis C virus and cellular stress response: implications to molecular pathogenesis of liver diseases, Viruses, 4, 2251, 10.3390/v4102251
Weber, 2013, Myofibroblast-mediated mechanisms of pathological remodelling of the heart, Nat Rev Cardiol, 10, 15, 10.1038/nrcardio.2012.158
Kong, 2013, The pathogenesis of cardiac fibrosis, Cell Mol Life Sci
Wynn, 2011, Integrating mechanisms of pulmonary fibrosis, J Exp Med, 208, 1339, 10.1084/jem.20110551
Duffield, 2013, Host responses in tissue repair and fibrosis, Annu Rev Pathol, 8:, 241, 10.1146/annurev-pathol-020712-163930
Otranto, 2012, The role of the myofibroblast in tumor stroma remodeling, Cell Adh Migr, 6, 203, 10.4161/cam.20377
Eyden, 2005, The myofibroblast a study of normal, reactive and neoplastic tissues, with an emphasis on ultrastructure. Part 2-tumours and tumour-like lesions, J Submicrosc Cytol Pathol, 37, 231
Hinz, 2010, The myofibroblast: paradigm for a mechanically active cell, J Biomech, 43, 146, 10.1016/j.jbiomech.2009.09.020
Follonier Castella, 2010, Regulation of myofibroblast activities: calcium pulls some strings behind the scene, Exp Cell Res, 316, 2390, 10.1016/j.yexcr.2010.04.033
Lin, 2008, Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney, Am J Pathol, 173, 1617, 10.2353/ajpath.2008.080433
Kalluri, 2009, The basics of epithelial-mesenchymal transition, J Clin Invest, 119, 1420, 10.1172/JCI39104
Liu, 2004, Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention, J Am Soc Nephrol, 15, 1, 10.1097/01.ASN.0000106015.29070.E7
Humphreys, 2010, Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis, Am J Pathol, 176, 85, 10.2353/ajpath.2010.090517
Kida, 2011, Pivotal role of pericytes in kidney fibrosis, Clin Exp Pharmacol Physiol, 38, 467, 10.1111/j.1440-1681.2011.05531.x
Le Hir, 2005, Characterization of renal interstitial fibroblast-specific protein 1/S100A4-positive cells in healthy and inflamed rodent kidneys, Histochem Cell Biol, 123, 335, 10.1007/s00418-005-0788-z
Mlodzik, 1995, Ecto-5′-nucleotidase is expressed by pericytes and fibroblasts in the rat heart, Histochem Cell Biol, 103, 227, 10.1007/BF01454028
Kim, 2006, Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix, Proc Natl Acad Sci USA, 103, 13180, 10.1073/pnas.0605669103
Zeisberg, 2007, Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition, J Biol Chem, 282, 23337, 10.1074/jbc.M700194200
Rastaldi, 2002, Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies, Kidney Int, 62, 137, 10.1046/j.1523-1755.2002.00430.x
Zeisberg, 2003, BMP-7 counteracts TGF-β1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury, Nat Med, 9, 964, 10.1038/nm888
Iwano, 2002, Evidence that fibroblasts derive from epithelium during tissue fibrosis, J Clin Invest, 110, 341, 10.1172/JCI0215518
Chu, 2011, Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis, Hepatology, 53, 1685, 10.1002/hep.24206
Rock, 2011, Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition, Proc Natl Acad Sci USA, 108, E1475, 10.1073/pnas.1117988108
Zeisberg, 2007, Endothelial-to-mesenchymal transition contributes to cardiac fibrosis, Nat Med, 13, 952, 10.1038/nm1613
Phua, 2013, Distinct sites of renal fibrosis in Crim1 mutant mice arise from multiple cellular origins, J Pathol, 229, 685, 10.1002/path.4155
Medici, 2010, Conversion of vascular endothelial cells into multipotent stem-like cells, Nat Med, 16, 1400, 10.1038/nm.2252
De Palma, 2005, Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors, Cancer Cell, 8, 211, 10.1016/j.ccr.2005.08.002
De Palma, 2003, Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells, Nat Med, 9, 789, 10.1038/nm871
Ning, 2011, Mesenchymal stem cell marker Stro-1 is a 75 kDa endothelial antigen, Biochem Biophys Res Commun, 413, 353, 10.1016/j.bbrc.2011.08.104
Tigges, 2012, A novel and simple method for culturing pericytes from mouse brain, Microvasc Res, 84, 74, 10.1016/j.mvr.2012.03.008
Gitlin, 1983, Culture of retinal capillary cells using selective growth media, Microvasc Res, 26, 74, 10.1016/0026-2862(83)90056-0
Russo, 2006, The bone marrow functionally contributes to liver fibrosis, Gastroenterology, 130, 1807, 10.1053/j.gastro.2006.01.036
Forbes, 2004, A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis, Gastroenterology, 126, 955, 10.1053/j.gastro.2004.02.025
Scholten, 2011, Migration of fibrocytes in fibrogenic liver injury, Am J Pathol, 179, 189, 10.1016/j.ajpath.2011.03.049
Kisseleva, 2011, Anti-fibrogenic strategies and the regression of fibrosis, Best Pract Res Clin Gastroenterol, 25, 305, 10.1016/j.bpg.2011.02.011
Moore, 2005, CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury, Am J Pathol, 166, 675, 10.1016/S0002-9440(10)62289-4
Moore, 2006, The role of CCL12 in the recruitment of fibrocytes and lung fibrosis, Am J Resp Cell Mol Biol, 35, 175, 10.1165/rcmb.2005-0239OC
Phillips, 2004, Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis, J Clin Invest, 114, 438, 10.1172/JCI200420997
Lebleu, 2013, Origin and function of myofibroblasts in kidney fibrosis, Nat Med, 19, 1047, 10.1038/nm.3218
Falkenham, 2013, Early fibroblast progenitor cell migration to the AngII-exposed myocardium is not CXCL12 or CCL2 dependent as previously thought, Am J Pathol, 183, 459, 10.1016/j.ajpath.2013.04.011
Frangogiannis, 2007, Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy, Circulation, 115, 584, 10.1161/CIRCULATIONAHA.106.646091
Haudek, 2006, Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice, Proc Natl Acad Sci USA, 103, 18284, 10.1073/pnas.0608799103
Mollmann, 2006, Bone marrow-derived cells contribute to infarct remodelling, Cardiovasc Res, 71, 661, 10.1016/j.cardiores.2006.06.013
et al. Gastroenterology 137
Kisseleva, 2006, Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis, J Hepatol, 45, 429, 10.1016/j.jhep.2006.04.014
Hashimoto, 2004, Bone marrow-derived progenitor cells in pulmonary fibrosis, J Clin Invest, 113, 243, 10.1172/JCI200418847
Roufosse, 2006, Bone marrow-derived cells do not contribute significantly to collagen I synthesis in a murine model of renal fibrosis, J Am Soc Nephrol, 17, 775, 10.1681/ASN.2005080795
Reich, 2013, Fibrocytes develop outside the kidney but contribute to renal fibrosis in a mouse model, Kidney Int, 84, 78, 10.1038/ki.2013.84
Picard, 2008, Origin of renal myofibroblasts in the model of unilateral ureter obstruction in the rat, Histochem Cell Biol, 130, 141, 10.1007/s00418-008-0433-8
Iwaisako, 2012, What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis, J Gastroenterol Hepatol, 27, 65, 10.1111/j.1440-1746.2011.07002.x
Gabbiani, 1996, The cellular derivation and the life span of the myofibroblast, Pathol Res Pract, 192, 708, 10.1016/S0344-0338(96)80092-6
Rajkumar, 2005, Shared expression of phenotypic markers in systemic sclerosis indicates a convergence of pericytes and fibroblasts to a myofibroblast lineage in fibrosis, Arthritis Res Ther, 7, R1113, 10.1186/ar1790
Levinson, 2005, Foxd1-dependent signals control cellularity in the renal capsule a structure required for normal renal development, Development, 132, 529, 10.1242/dev.01604
Hatini, 1996, Essential role of stromal mesenchyme in kidney morphogenesis revealed by targeted disruption of Winged Helix transcription factor BF-2, Genes Dev, 10, 1467, 10.1101/gad.10.12.1467
Grgic, 2012, The origin of interstitial myofibroblasts in chronic kidney disease, Pediatr Nephrol, 27, 183, 10.1007/s00467-011-1772-6
Goritz, 2011, A pericyte origin of spinal cord scar tissue, Science, 333, 238, 10.1126/science.1203165
Dulauroy, 2012, Lineage tracing and genetic ablation of ADAM12+ perivascular cells identify a major source of profibrotic cells during acute tissue injury, Nat Med, 18, 1262, 10.1038/nm.2848
Armulik, 2011, Pericytes: developmental, physiological, and pathological perspectives, problems, and promises, Dev Cell, 21, 193, 10.1016/j.devcel.2011.07.001
Crisan, 2009, Perivascular multipotent progenitor cells in human organs, Ann NY Acad Sci, 1176:, 118, 10.1111/j.1749-6632.2009.04967.x
Chen, 2011, Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis, Kidney Int, 80, 1170, 10.1038/ki.2011.208
Lin, 2011, Targeting endothelium-pericyte crosstalk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis, Am J Pathol, 178, 911, 10.1016/j.ajpath.2010.10.012
Asada, 2011, Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice, J Clin Invest, 121, 3981, 10.1172/JCI57301
Seikrit, 2013, Biological responses to PDGF-AA versus PDGF-CC in renal fibroblasts, Nephrol Dial Transpl, 28, 889, 10.1093/ndt/gfs509
Yamate, 1996, Immunohistochemical study of rat renal interstitial fibrosis induced by repeated injection of cisplatin, with special reference to the kinetics of macrophages and myofibroblasts, Toxicol Pathol, 24, 199, 10.1177/019262339602400208
Degryse, 2010, Repetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis, Am J Physiol Lung Cell Mol Physiol, 299, L442, 10.1152/ajplung.00026.2010
Shi, 1998, Evidence of hepatocyte apoptosis in rat liver after the administration of carbon tetrachloride, Am J Pathol, 153, 515, 10.1016/S0002-9440(10)65594-0
Grgic, 2012, Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis, Kidney Int, 82, 172, 10.1038/ki.2012.20
Koesters, 2010, Tubular overexpression of transforming growth factor-β1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells, Am J Pathol, 177, 632, 10.2353/ajpath.2010.091012
Friedman, 2013, Therapy for fibrotic diseases: nearing the starting line, Sci Transl Med, 5, 10.1126/scitranslmed.3004700
Wick, 2013, The immunology of fibrosis, Annu Rev Immunol, 31:, 107, 10.1146/annurev-immunol-032712-095937
Zhang, 1993, Enhanced IL-1β and tumor necrosis factor-α release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure, J Immunol, 150, 4188, 10.4049/jimmunol.150.9.4188
Piguet, 1989, Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis, J Exp Med, 170, 655, 10.1084/jem.170.3.655
Tomita, 2006, Tumour necrosis factor-α signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice, Gut, 55, 415, 10.1136/gut.2005.071118
He, 2010, Inflammation and fibrosis during Chlamydia pneumoniae infection is regulated by IL-1 and the NLRP3/ASC inflammasome, J Immunol, 184, 5743, 10.4049/jimmunol.0903937
Vilaysane, 2010, The NLRP3 inflammasome promotes renal inflammation and contributes to CKD, J Am Soc Nephrol, 21, 1732, 10.1681/ASN.2010020143
Wilson, 2010, Bleomycin and IL-1β-mediated pulmonary fibrosis is IL-17A dependent, J Exp Med, 207, 535, 10.1084/jem.20092121
Feng, 2009, IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenol-induced heart failure, Exp Mol Pathol, 87, 212, 10.1016/j.yexmp.2009.06.001
Foster, 2012, Interleukin (IL)-17/IL-22-producing T cells enriched within the liver of patients with chronic hepatitis C viral (HCV) infection, Dig Dis Sci, 57, 381, 10.1007/s10620-011-1997-z
Rosenbloom, 2013, Strategies for anti-fibrotic therapies, Biochim Biophys Acta, 1832, 1088, 10.1016/j.bbadis.2012.12.007
Gasse, 2011, IL-1 and IL-23 mediate early IL-17A production in pulmonary inflammation leading to late fibrosis, PLoS One, 6, e23185, 10.1371/journal.pone.0023185
Nakashima, 2012, Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts, J Immunol, 188, 3573, 10.4049/jimmunol.1100591
Lo Re, 2010, IL-17A-producing γδT and Th17 lymphocytes mediate lung inflammation but not fibrosis in experimental silicosis, J Immunol, 184, 6367, 10.4049/jimmunol.0900459
Shi, 1997, Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses, Proc Natl Acad Sci USA, 94, 10663, 10.1073/pnas.94.20.10663
Furuie, 1997, Altered accessory cell function of alveolar macrophages a possible mechanism for induction of Th2 secretory profile in idiopathic pulmonary fibrosis, Eur Respir J, 10, 787, 10.1183/09031936.97.10040787
Mavalia, 1997, Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis, Am J Pathol, 151, 1751
Yoshizaki, 2010, Cell adhesion molecules regulate fibrotic process via Th1/Th2/Th17 cell balance in a bleomycin-induced scleroderma model, J Immunol, 185, 2502, 10.4049/jimmunol.0901778
Kolodsick, 2004, Protection from fluorescein isothiocyanate-induced fibrosis in IL-13-deficient, but not IL-4-deficient, mice results from impaired collagen synthesis by fibroblasts, J Immunol, 172, 4068, 10.4049/jimmunol.172.7.4068
Weng, 2009, The etiology of liver damage imparts cytokines transforming growth factor-β1 or interleukin-13 as driving forces in fibrogenesis, Hepatology, 50, 230, 10.1002/hep.22934
Shimamura, 2008, Novel role of IL-13 in fibrosis induced by nonalcoholic steatohepatitis and its amelioration by IL-13R-directed cytotoxin in a rat model, J Immunol, 181, 4656, 10.4049/jimmunol.181.7.4656
Han, 2011, Th2-like immune response in radiation-induced lung fibrosis, Oncol Rep, 26, 383
Chiaramonte, 2003, Regulation and function of the interleukin 13 receptor-α2 during a T helper cell type 2-dominant immune response, J Exp Med, 197, 687, 10.1084/jem.20020903
Duffield, 2005, Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair, J Clin Invest, 115, 56, 10.1172/JCI200522675
Duffield, 2005, Conditional ablation of macrophages halts progression of crescentic glomerulonephritis, Am J Pathol, 167, 1207, 10.1016/S0002-9440(10)61209-6
Castano, 2009, Serum amyloid P inhibits fibrosis through FcγR-dependent monocyte-macrophage regulation in vivo, Sci Transl Med, 1, 10.1126/scitranslmed.3000111
Mosser, 2008, Exploring the full spectrum of macrophage activation, Nat Rev Immunol, 8, 958, 10.1038/nri2448
Wynn, 2010, Macrophages: master regulators of inflammation and fibrosis, Semin Liver Dis, 30, 245, 10.1055/s-0030-1255354
Wahl, 1990, Macrophage production of TGFβ and regulation by TGFβ, Ann NY Acad Sci, 593:, 188, 10.1111/j.1749-6632.1990.tb16111.x
Henke, 1993, Macrophage production of basic fibroblast growth factor in the fibroproliferative disorder of alveolar fibrosis after lung injury, Am J Pathol, 143, 1189
Martinet, 1987, Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis, N Engl J Med, 317, 202, 10.1056/NEJM198707233170404
Prasse, 2006, A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18, Am J Respir Crit Care Med, 173, 781, 10.1164/rccm.200509-1518OC
Chen, 2013, Pirfenidone inhibits macrophage infiltration in 5/6 nephrectomized rats, Am J Physiol Renal Physiol, 304, F676, 10.1152/ajprenal.00507.2012
Spencer, 2010, Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation, Am J Physiol Endocrinol Metab, 299, E1016, 10.1152/ajpendo.00329.2010
Nishida, 2005, Adoptive transfer of macrophages ameliorates renal fibrosis in mice, Biochem Biophys Res Commun, 332, 11, 10.1016/j.bbrc.2005.04.083
Murai, 2009, Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis, Nat Immunol, 10, 1178, 10.1038/ni.1791
Strien, 2010, Anti-inflammatory effect by lentiviral-mediated overexpression of IL-10 or IL-1 receptor antagonist in rat glial cells and macrophages, Gene Ther, 17, 662, 10.1038/gt.2010.8
Briscoe, 2013, The mechanisms of Hedgehog signalling and its roles in development and disease, Nat Rev Mol Cell Biol, 14, 416, 10.1038/nrm3598
Hu, 2006, GLI3-dependent transcriptional repression of Gli1, Gli2 and kidney patterning genes disrupts renal morphogenesis, Development, 133, 569, 10.1242/dev.02220
Yauch, 2008, A paracrine requirement for hedgehog signalling in cancer, Nature, 455, 406, 10.1038/nature07275
Shin, 2011, Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder, Nature, 472, 110, 10.1038/nature09851
Choi, 2011, The role of Hedgehog signaling in fibrogenic liver repair, Int J Biochem Cell Biol, 43, 238, 10.1016/j.biocel.2010.10.015
Michelotti, 2013, Smoothened is a master regulator of adult liver repair, J Clin Invest, 123, 2380
Stewart, 2003, Expression of the developmental Sonic hedgehog (Shh) signalling pathway is up-regulated in chronic lung fibrosis and the Shh receptor patched 1 is present in circulating T lymphocytes, J Pathol, 199, 488, 10.1002/path.1295
Fabian, 2012, Hedgehog-Gli pathway activation during kidney fibrosis, Am J Pathol, 180, 1441, 10.1016/j.ajpath.2011.12.039
Ding, 2012, Sonic hedgehog signaling mediates epithelial-mesenchymal communication and promotes renal fibrosis, J Am Soc Nephrol, 23, 801, 10.1681/ASN.2011060614
Sahebjam, 2012, The utility of hedgehog signaling pathway inhibition for cancer, Oncologist, 17, 1090, 10.1634/theoncologist.2011-0450
Jenkins, 2009, Hedgehog signalling: emerging evidence for non-canonical pathways, Cell Signal, 21, 1023, 10.1016/j.cellsig.2009.01.033
Floege, 2008, A new look at platelet-derived growth factor in renal disease, J Am Soc Nephrol, 19, 12, 10.1681/ASN.2007050532
Leask, 2010, Potential therapeutic targets for cardiac fibrosis: TGFβ, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation, Circ Res, 106, 1675, 10.1161/CIRCRESAHA.110.217737
Rajkumar, 2006, Platelet-derived growth factor-β receptor activation is essential for fibroblast and pericyte recruitment during cutaneous wound healing, Am J Pathol, 169, 2254, 10.2353/ajpath.2006.060196
Campanholle, 2013, Cellular mechanisms of tissue fibrosis. 3. Novel mechanisms of kidney fibrosis, Am J Physiol Cell Physiol, 304, C591, 10.1152/ajpcell.00414.2012
Zymek, 2006, The role of platelet-derived growth factor signaling in healing myocardial infarcts, J Am Coll Cardiol, 48, 2315, 10.1016/j.jacc.2006.07.060
Liao, 2010, Cardiac mast cells cause atrial fibrillation through PDGF-A-mediated fibrosis in pressure-overloaded mouse hearts, J Clin Invest, 120, 242, 10.1172/JCI39942
Lewis, 2005, Airway fibroblasts exhibit a synthetic phenotype in severe asthma, J Allergy Clin Immunol, 115, 534, 10.1016/j.jaci.2004.11.051
Mukherjee, 2013, Platelet derived growth factor-evoked Ca2+ wave and matrix gene expression through phospholipase C in human pulmonary fibroblast, Int J Biochem Cell Biol, 45, 1516, 10.1016/j.biocel.2013.04.018
Martin, 2013, Platelet-derived growth factor (PDGF)-C neutralization reveals differential roles of PDGF receptors in liver and kidney fibrosis, Am J Pathol, 182, 107, 10.1016/j.ajpath.2012.09.006
Huang, 2013, Blockade of KCa3.1 ameliorates renal fibrosis through the TGF-β1/Smad pathway in diabetic mice, Diabetes, 62, 2923, 10.2337/db13-0135
Yamamoto, 1993, Expression of transforming growth factor-β is elevated in human and experimental diabetic nephropathy, Proc Natl Acad Sci USA, 90, 1814, 10.1073/pnas.90.5.1814
Pohlers, 2007, Constitutive upregulation of the transforming growth factor-β pathway in rheumatoid arthritis synovial fibroblasts, Arthritis Res Ther, 9, R59, 10.1186/ar2217
Bujak, 2007, The role of TGF-β signaling in myocardial infarction and cardiac remodeling, Cardiovasc Res, 74, 184, 10.1016/j.cardiores.2006.10.002
Daniels, 2004, Imatinib mesylate inhibits the profibrogenic activity of TGF-β and prevents bleomycin-mediated lung fibrosis, J Clin Invest, 114, 1308, 10.1172/JCI200419603
Pohlers, 2009, TGF-β and fibrosis in different organs-molecular pathway imprints, Biochim Biophys Acta, 1792, 746, 10.1016/j.bbadis.2009.06.004
Wipff, 2008, Integrins and the activation of latent transforming growth factor-β1-an intimate relationship, Eur J Cell Biol, 87, 601, 10.1016/j.ejcb.2008.01.012
Saharinen, 2000, Specific sequence motif of 8-Cys repeats of TGF-β binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-β, Mol Biol Cell, 11, 2691, 10.1091/mbc.11.8.2691
Yu, 2000, Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis, Genes Dev, 14, 163, 10.1101/gad.14.2.163
Poczatek, 2000, Glucose stimulation of transforming growth factor-β bioactivity in mesangial cells is mediated by thrombospondin-1, Am J Pathol, 157, 1353, 10.1016/S0002-9440(10)64649-4
Wahl, 1993, Reversal of acute and chronic synovial inflammation by anti-transforming growth factor-β, J Exp Med, 177, 225, 10.1084/jem.177.1.225
Ledbetter, 2000, Renal fibrosis in mice treated with human recombinant transforming growth factor-β2, Kidney Int, 58, 2367, 10.1046/j.1523-1755.2000.00420.x
Border, 1990, Suppression of experimental glomerulonephritis by antiserum against transforming growth factor-β1, Nature, 346, 371, 10.1038/346371a0
Sato, 2003, Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction, J Clin Invest, 112, 1486, 10.1172/JCI200319270
Denton, 2007, Recombinant human anti-transforming growth factor-β1 antibody therapy in systemic sclerosis a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192, Arthritis Rheum, 56, 323, 10.1002/art.22289
Beyer, 2013, Tyrosine kinase signaling in fibrotic disorders: Translation of basic research to human disease, Biochim Biophys Acta, 1832, 897, 10.1016/j.bbadis.2012.06.008
Baselga, 2009, Novel anticancer targets: revisiting ERBB2 and discovering ERBB3, Nat Rev Cancer, 9, 463, 10.1038/nrc2656
Yarden, 2001, Untangling the ErbB signalling network, Nat Rev Mol Cell Biol, 2, 127, 10.1038/35052073
Blaine, 2009, Epidermal growth factor receptor regulates pancreatic fibrosis, Am J Physiol Gastrointest Liver Physiol, 297, G434, 10.1152/ajpgi.00152.2009
Pang, 2010, A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy, Kidney Int, 78, 257, 10.1038/ki.2010.154
Terzi, 2000, Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injury, J Clin Invest, 106, 225, 10.1172/JCI8315
Liu, 2012, Genetic or pharmacologic blockade of EGFR inhibits renal fibrosis, J Am Soc Nephrol, 23, 854, 10.1681/ASN.2011050493
Tang, 2013, Sustained activation of EGFR triggers renal fibrogenesis after acute kidney injury, Am J Pathol, 183, 160, 10.1016/j.ajpath.2013.04.005
Chen, 2012, EGFR signaling promotes TGFβ-dependent renal fibrosis, J Am Soc Nephrol, 23, 215, 10.1681/ASN.2011070645
Liu, 1996, Up-regulated expression of transforming growth factor-α in the bronchiolar-alveolar duct regions of asbestos-exposed rats, Am J Pathol, 149, 205
Madtes, 1994, Expression of transforming growth factor-α and epidermal growth factor receptor is increased following bleomycin-induced lung injury in rats, Am J Respir Cell Mol Biol, 11, 540, 10.1165/ajrcmb.11.5.7524566
Hardie, 2004, Conditional expression of transforming growth factor-α in adult mouse lung causes pulmonary fibrosis, Am J Physiol Lung Cell Mol Physiol, 286, L741, 10.1152/ajplung.00208.2003
Ishii, 2006, Gefitinib prevents bleomycin-induced lung fibrosis in mice, Am J Respir Crit Care Med, 174, 550, 10.1164/rccm.200509-1534OC
Hardie, 2008, EGF receptor tyrosine kinase inhibitors diminish transforming growth factor-α-induced pulmonary fibrosis, Am J Physiol Lung Cell Mol Physiol, 294, L1217, 10.1152/ajplung.00020.2008
Suzuki, 2003, Epidermal growth factor receptor tyrosine kinase inhibition augments a murine model of pulmonary fibrosis, Cancer Res, 63, 5054
Fukumoto, 2010, Amphiregulin attenuates bleomycin-induced pneumopathy in mice, Am J Physiol Lung Cell Mol Physiol, 298, L131, 10.1152/ajplung.90576.2008
Kular, 2011, The CCN family a new class of inflammation modulators?, Biochimie, 93, 377, 10.1016/j.biochi.2010.11.010
Hinz, 2012, Recent developments in myofibroblast biology: paradigms for connective tissue remodeling, Am J Pathol, 180, 1340, 10.1016/j.ajpath.2012.02.004
Kennedy, 2007, CCN2 is necessary for the function of mouse embryonic fibroblasts, Exp Cell Res, 313, 952, 10.1016/j.yexcr.2006.12.006
Ponticos, 2009, Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen, Arthritis Rheum, 60, 2142, 10.1002/art.24620
Huang, 2012, Regulation of hepatic stellate cells by connective tissue growth factor, Front Biosci, 17:, 2495, 10.2741/4067
Ren, 2013, LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited by DKK-1, Proc Natl Acad Sci USA, 110, 1440, 10.1073/pnas.1211179110
Angers, 2009, Proximal events in Wnt signal transduction, Nat Rev Mol Cell Biol, 10, 468, 10.1038/nrm2717
Clevers, 2006, Wnt/β-catenin signaling in development and disease, Cell, 127, 469, 10.1016/j.cell.2006.10.018
Cheon, 2002, β-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds, Proc Natl Acad Sci USA, 99, 6973, 10.1073/pnas.102657399
Lam, 2011, β-Catenin signaling a novel mediator of fibrosis and potential therapeutic target, Curr Opin Rheumatol, 23, 562, 10.1097/BOR.0b013e32834b3309
Beyer, 2012, β-Catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis, Ann Rheum Dis, 71, 761, 10.1136/annrheumdis-2011-200568
Beyer, 2013, Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis, Ann Rheum Dis, 72, 1255, 10.1136/annrheumdis-2012-202544
Akhmetshina, 2012, Activation of canonical Wnt signalling is required for TGFβ-mediated fibrosis, Nat Commun, 3:, 735, 10.1038/ncomms1734
Brack, 2007, Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis, Science, 317, 807, 10.1126/science.1144090
Lam, 2011, Nuclear β-catenin is increased in systemic sclerosis pulmonary fibrosis and promotes lung fibroblast migration and proliferation, Am J Respir Cell Mol Biol, 45, 915, 10.1165/rcmb.2010-0113OC
Chilosi, 2003, Aberrant Wnt/β-catenin pathway activation in idiopathic pulmonary fibrosis, Am J Pathol, 162, 1495, 10.1016/S0002-9440(10)64282-4
Hao, 2011, Targeted inhibition of β-catenin/CBP signaling ameliorates renal interstitial fibrosis, J Am Soc Nephrol, 22, 1642, 10.1681/ASN.2010101079
Surendran, 2002, A role for Wnt-4 in renal fibrosis, Am J Physiol Renal Physiol, 282, F431, 10.1152/ajprenal.0009.2001
Surendran, 2004, Matrilysin (MMP-7) expression in renal tubular damage: association with Wnt4, Kidney Int, 65, 2212, 10.1111/j.1523-1755.2004.00641.x
Fortini, 2009, Notch signaling: the core pathway and its posttranslational regulation, Dev Cell, 16, 633, 10.1016/j.devcel.2009.03.010
Borggrefe, 2012, Fine-tuning of the intracellular canonical Notch signaling pathway, Cell Cycle, 11, 264, 10.4161/cc.11.2.18995
Morrissey, 2002, Transforming growth factor-β induces renal epithelial Jagged-1 expression in fibrotic disease, J Am Soc Nephrol, 13, 1499, 10.1097/01.ASN.0000017905.77985.4A
Bielesz, 2010, Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans, J Clin Invest, 120, 4040, 10.1172/JCI43025
Djudjaj, 2012, Notch-3 receptor activation drives inflammation and fibrosis following tubulointerstitial kidney injury, J Pathol, 228, 286, 10.1002/path.4076
Dees, 2011, Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis, Ann Rheum Dis, 70, 1304, 10.1136/ard.2010.134742
Liu, 2009, Notch1 signaling in FIZZ1 induction of myofibroblast differentiation, Am J Pathol, 174, 1745, 10.2353/ajpath.2009.080618
Spee, 2010, Characterisation of the liver progenitor cell niche in liver diseases: potential involvement of Wnt and Notch signalling, Gut, 59, 247, 10.1136/gut.2009.188367